Mathieu Lupien

Princess Margaret Cancer Centre 
"Mathieu Lupien"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kohan AA, Lupien M, Cescon D, et al. (2023) Detection of metabolic adaptation in a triple-negative breast cancer animal model with [F]choline-PET imaging as a surrogate for drug resistance. European Journal of Nuclear Medicine and Molecular Imaging
Grillo G, Keshavarzian T, Linder S, et al. (2023) Transposable elements are co-opted as oncogenic regulatory elements by lineage-specific transcription factors in prostate cancer. Cancer Discovery
Cameron S, Deblois G, Hawley JR, et al. (2023) Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer. Oncogene
Yanchus C, Drucker KL, Kollmeyer TM, et al. (2022) A noncoding single-nucleotide polymorphism at 8q24 drives -mutant glioma formation. Science (New York, N.Y.). 378: 68-78
Bahl S, Carroll JS, Lupien M. (2022) Chromatin Variants Reveal the Genetic Determinants of Oncogenesis in Breast Cancer. Cold Spring Harbor Perspectives in Medicine
Wu Q, Nie DY, Ba-Alawi W, et al. (2022) PRMT inhibition induces a viral mimicry response in triple-negative breast cancer. Nature Chemical Biology
Richards LM, Whitley OKN, MacLeod G, et al. (2021) Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity. Nature Cancer. 2: 157-173
Payer LM, Steranka JP, Kryatova MS, et al. (2021) insertion variants alter gene transcript levels. Genome Research
Nikolic A, Singhal D, Ellestad K, et al. (2021) Copy-scAT: Deconvoluting single-cell chromatin accessibility of genetic subclones in cancer. Science Advances. 7: eabg6045
Hawley JR, Zhou S, Arlidge C, et al. (2021) Reorganization of the 3D genome pinpoints non-coding drivers of primary prostate tumors. Cancer Research
See more...